San Francisco, CA

Our History

The path to get here

In December 2007, while pursuing their graduate degrees under the supervision of Professor Tejal Desai at the University of California, San Francisco, the founders of Nano Precision Medical began their entrepreneurial journey by winning a series of business plan competitions. In 2009, the project was awarded a Catalyst grant from the California Institute for Quantitative Biology (QB3), providing the first significant funding to translate the original idea into a startup company. This funding enabled the hiring of Will Fischer, who later became the first employee of the company and continues with us presently.

Business Plan Competition Accolades

First Place and Trade Show Winner
Hong Kong University of Science and Technology International Business Plan Competition (2009)

People’s Choice Winner
Intel + UC Berkeley Technology Entrepreneurship Challenge (Fall 2008)

UC Berkeley Venture Lab Competition
(Fall 2008)

Second Place
ASME Innovator Showcase (Summer 2008)

International MBA Jungle Business Plan Competition (Spring 2008)

First Place
UC Berkeley Business Plan Competition (Spring 2008)

First Place
UC Berkeley Nanoclub Technology Challenge (Fall 2007)

In 2011, Dr. Kayte Fischer and Dr. Adam Mendelsohn dedicated themselves full-time towards realizing Nano Precision Medical’s vision. Dr. Lily Peng completed her M.D. and Ph.D. in 2012, and remains actively engaged with Nano Precision Medical in an advisory capacity. After spending its early years within the QB3 incubator network, Nano Precision Medical moved into its own space in Emeryville, CA in August 2013. This facility provides plenty of space between offices and the lab, an inspiring view of the San Francisco Bay and Bay Bridge, and a perfect environment for Nano Precision Medical to grow as it continues making progress.

From 2012 to 2019, NPM chose to focus its efforts on research for manufacturing processes and formulation design for a GLP-1 agonist product targeting Type II Diabetes. In 2019, Nano Precision Medical was excited to demonstrate a commercially attractive human product (in animals), resulting in a shift in focus to advancing NPM-119 towards clinical trials.

Based on the founders’ experience at the UC and its location in the heart of the San Francisco Bay Area, Nano Precision Medical maintains a culture of creativity, energy, and integrity, while relentlessly advancing its technology and products. By combining the flexibility and camaraderie of a tech startup with the precision and quality of a pharmaceutical company, Nano Precision Medical has set its course to make a difference.